Development of composition and technology of combination drug with neurally mediated action «Memofit»

Journal Title: ScienceRise: Pharmaceutical Science - Year 2017, Vol 0, Issue 6

Abstract

<p> </p><p><strong>Aim. </strong>The aim of this work is to<strong> </strong>develop composition of combination drug in the form of hard-gelatin capsules «Memofit», determine technological and microbiological parameters of intermediate products and ready medicinal product and develop of manufacturing process for capsules «Memofit».<strong></strong></p><p><strong>Methods of the research. </strong>Investigations presented in the article were performed in accordance with the <em>procedures </em>described by the <em>State Pharmacopoeia of Ukraine</em> (SPh Ukraine).<strong></strong></p><p><strong>The results of the research.</strong> Necessity of the development of dietary supplement to provide special dietary properties for the purpose of regulation of functions and systems of the organism within the physiologically normal states under the nervous system dysfunction was substantiated. Results of the study of pharmaco-technological and microbiological parameters of dry extracts that are included as a compound of hard-gelatin capsules «Memofit» were presented. Optimal technological parameters for manufacturing process of capsules «Memofit» were proposed. Results of mass balance for a batch of capsules «Memofit» proved rationality of selected manufacturing process were given. Technology of manufacturing process of capsules «Memofit» was introduced into the production on the TOV “DZ “GNCLS”.<strong></strong></p><p><strong>Conclusions</strong>. Possibility of the development of solid formulations in the form of capsules was established based on the obtained experimental findings of the determination of pharmaco-technological and microbiological parameters of dry extracts. It was shown that capsules «Memofit» are used in dietary food ration as additional source of biologically active substances for promoting normalization of brain function and sleep, improvement of attentiveness. This preparation has general tonic properties and improves mental and physical efficiency. Manufacturing process and process flow chart for this medication was substantiated<strong></strong></p>

Authors and Affiliations

Elena Savelieva, Inna Vladymyrova, Tatyana Tishakova, Olga Levashova

Keywords

Related Articles

Algorithm for carrying out a procedure for verification of a spectrophotometric method for analysis of solid-dosed dosage forms according to the requirements of SPHU 2.0

<p><strong>Aim</strong><strong>. </strong>The increase in the pharmaceutical market of Ukraine of the range of medicines leads to stricter requirements for their quality. According to the requirements of international st...

Identification and quantitative determination of steroidal compounds in the plant material of cabbage

<p>Vegetable crops are inexhaustible source of biologically active compounds. Cabbage (Brassica oleracea L.) – is a plant that has been extensively used in folk medicine of different countries of the world for the treatm...

Визначення сертиндолу у біологічному матеріалі методом газової хроматографії – мас-спектрометрії

<p>Лікування антипсихотичним препаратом нового покоління сертиндолом при передозуванні чи комбінуванні його з деякими лікарськими засобами, супроводжується пролонгацією QT інтервалу та злоякісним нейролептичним синдромом...

Analysis of psychotropic medicines triazolam, estazolam and alprazolam mixture using high-performance liquid chromatography method

Poisoning of benzodiazepines, particularly triazolam, estazolam and alprazolam usually is caused by consumption of the drug in bigger doses than prescribed. So, for the fast determination of material caused poisoning, s...

Development of combined composition pessaries for genital herpes treatment

<p>Recently, the problem of therapy, as well as creation of effective remedies applied for genital herpes (GH) treatment is relevant for modern gynecology and pharmacy.</p><p><strong>Aim</strong>. Development of the comb...

Download PDF file
  • EP ID EP647880
  • DOI 10.15587/2519-4852.2017.119744
  • Views 171
  • Downloads 0

How To Cite

Elena Savelieva, Inna Vladymyrova, Tatyana Tishakova, Olga Levashova (2017). Development of composition and technology of combination drug with neurally mediated action «Memofit». ScienceRise: Pharmaceutical Science, 0(6), 38-44. https://www.europub.co.uk/articles/-A-647880